During the past decade, Universal Axon Clinical Research conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 6 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 6 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universal Axon Clinical Research" #1 sponsor was "Celgene" with 4 trials, followed by "Astellas Pharma Global Development, Inc." with 2 trials sponsored, "InGeneron, Inc." with 2 trials sponsored, "Veru Inc." with 2 trials sponsored and "Adaptive Phage Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universal Axon Clinical Research" #1 collaborator was "Syneos Health" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Universal Axon Clinical Research" are "Crohn Disease" (3 trials), "Hot Flashes" (2 trials), "Adenoma" (1 trials), "Androgen Resistant Prostatic Cancer" (1 trials) and "Breast Reconstruction" (1 trials). Many other conditions were trialed in "Universal Axon Clinical Research" in a lesser frequency.

Most popular intervention types in "Universal Axon Clinical Research" are "Drug" (16 trials), "Biological" (4 trials), "Other" (4 trials), "Device" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Ozanimod" (3 trials), "Adipose Derived Regenerative Cells" (2 trials), "Corticosteroid" (2 trials) and "fezolinetant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universal Axon Clinical Research" are 16 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Universal Axon Clinical Research". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Universal Axon Clinical Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Universal Axon Clinical Research, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".